Skip to content

Clinical trials

Recruiting Phase 2 Myeloproliferative Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 2 Status: Recruiting Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20192
20203
20212
20222
20233
20246
20256

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting26

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)3
City of Hope Medical Center2
Fred Hutchinson Cancer Center2
M.D. Anderson Cancer Center2
Masonic Cancer Center, University of Minnesota2
Memorial Sloan Kettering Cancer Center2
St. Petersburg State Pavlov Medical University2
University of Alabama at Birmingham2
Center for International Blood and Marrow Transplant Research1
Cogent Biosciences, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders26
Leukemia, Myeloid, Acute19
Myelodysplastic Syndromes16
Precursor Cell Lymphoblastic Leukemia-Lymphoma9
Leukemia, Myelogenous, Chronic, BCR-ABL Positive7
Primary Myelofibrosis6
Lymphoma, Non-Hodgkin5
Anemia, Refractory, with Excess of Blasts4
Leukemia3
Leukemia, Biphenotypic, Acute3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.

Visit Pharma Observatory